Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank Samples

Rationale: More than half of patients who receive thrombolysis for acute ischaemic stroke fail to recanalize. Elucidating biological factors which predict recanalization could identify therapeutic targets for increasing thrombolysis success.Hypothesis: We hypothesize that individual patient plasmin...

Full description

Bibliographic Details
Main Authors: Thomas Lillicrap, Charithani B. Keragala, Dominik F. Draxler, Jilly Chan, Heidi Ho, Stevi Harman, Be'eri Niego, Elizabeth Holliday, Christopher R. Levi, Carlos Garcia-Esperon, Neil Spratt, Prajwal Gyawali, Andrew Bivard, Mark W. Parsons, Joan Montaner, Alejandro Bustamante, Israel Fernandez Cadenas, Geoffrey Cloud, Jane M. Maguire, Lisa Lincz, Timothy Kleinig, John Attia, Simon Koblar, Monica Anne Hamilton-Bruce, Philip Choi, Bradford B. Worrall, Robert L. Medcalf
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.589628/full
_version_ 1818884188018835456
author Thomas Lillicrap
Thomas Lillicrap
Charithani B. Keragala
Dominik F. Draxler
Dominik F. Draxler
Dominik F. Draxler
Jilly Chan
Heidi Ho
Stevi Harman
Be'eri Niego
Elizabeth Holliday
Elizabeth Holliday
Christopher R. Levi
Christopher R. Levi
Christopher R. Levi
Carlos Garcia-Esperon
Carlos Garcia-Esperon
Neil Spratt
Neil Spratt
Prajwal Gyawali
Prajwal Gyawali
Andrew Bivard
Andrew Bivard
Andrew Bivard
Mark W. Parsons
Joan Montaner
Joan Montaner
Joan Montaner
Alejandro Bustamante
Israel Fernandez Cadenas
Geoffrey Cloud
Geoffrey Cloud
Jane M. Maguire
Lisa Lincz
Lisa Lincz
Lisa Lincz
Timothy Kleinig
Timothy Kleinig
John Attia
John Attia
Simon Koblar
Simon Koblar
Monica Anne Hamilton-Bruce
Monica Anne Hamilton-Bruce
Philip Choi
Philip Choi
Bradford B. Worrall
Bradford B. Worrall
Robert L. Medcalf
author_facet Thomas Lillicrap
Thomas Lillicrap
Charithani B. Keragala
Dominik F. Draxler
Dominik F. Draxler
Dominik F. Draxler
Jilly Chan
Heidi Ho
Stevi Harman
Be'eri Niego
Elizabeth Holliday
Elizabeth Holliday
Christopher R. Levi
Christopher R. Levi
Christopher R. Levi
Carlos Garcia-Esperon
Carlos Garcia-Esperon
Neil Spratt
Neil Spratt
Prajwal Gyawali
Prajwal Gyawali
Andrew Bivard
Andrew Bivard
Andrew Bivard
Mark W. Parsons
Joan Montaner
Joan Montaner
Joan Montaner
Alejandro Bustamante
Israel Fernandez Cadenas
Geoffrey Cloud
Geoffrey Cloud
Jane M. Maguire
Lisa Lincz
Lisa Lincz
Lisa Lincz
Timothy Kleinig
Timothy Kleinig
John Attia
John Attia
Simon Koblar
Simon Koblar
Monica Anne Hamilton-Bruce
Monica Anne Hamilton-Bruce
Philip Choi
Philip Choi
Bradford B. Worrall
Bradford B. Worrall
Robert L. Medcalf
author_sort Thomas Lillicrap
collection DOAJ
description Rationale: More than half of patients who receive thrombolysis for acute ischaemic stroke fail to recanalize. Elucidating biological factors which predict recanalization could identify therapeutic targets for increasing thrombolysis success.Hypothesis: We hypothesize that individual patient plasmin potential, as measured by in vitro response to recombinant tissue-type plasminogen activator (rt-PA), is a biomarker of rt-PA response, and that patients with greater plasmin response are more likely to recanalize early.Methods: This study will use historical samples from the Barcelona Stroke Thrombolysis Biobank, comprised of 350 pre-thrombolysis plasma samples from ischaemic stroke patients who received serial transcranial-Doppler (TCD) measurements before and after thrombolysis. The plasmin potential of each patient will be measured using the level of plasmin-antiplasmin complex (PAP) generated after in-vitro addition of rt-PA. Levels of antiplasmin, plasminogen, t-PA activity, and PAI-1 activity will also be determined. Association between plasmin potential variables and time to recanalization [assessed on serial TCD using the thrombolysis in brain ischemia (TIBI) score] will be assessed using Cox proportional hazards models, adjusted for potential confounders.Outcomes: The primary outcome will be time to recanalization detected by TCD (defined as TIBI ≥4). Secondary outcomes will be recanalization within 6-h and recanalization and/or haemorrhagic transformation at 24-h. This analysis will utilize an expanded cohort including ~120 patients from the Targeting Optimal Thrombolysis Outcomes (TOTO) study.Discussion: If association between proteolytic response to rt-PA and recanalization is confirmed, future clinical treatment may customize thrombolytic therapy to maximize outcomes and minimize adverse effects for individual patients.
first_indexed 2024-12-19T15:45:34Z
format Article
id doaj.art-86906486acd54bac865705d696765ecb
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-19T15:45:34Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-86906486acd54bac865705d696765ecb2022-12-21T20:15:21ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-11-011110.3389/fneur.2020.589628589628Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank SamplesThomas Lillicrap0Thomas Lillicrap1Charithani B. Keragala2Dominik F. Draxler3Dominik F. Draxler4Dominik F. Draxler5Jilly Chan6Heidi Ho7Stevi Harman8Be'eri Niego9Elizabeth Holliday10Elizabeth Holliday11Christopher R. Levi12Christopher R. Levi13Christopher R. Levi14Carlos Garcia-Esperon15Carlos Garcia-Esperon16Neil Spratt17Neil Spratt18Prajwal Gyawali19Prajwal Gyawali20Andrew Bivard21Andrew Bivard22Andrew Bivard23Mark W. Parsons24Joan Montaner25Joan Montaner26Joan Montaner27Alejandro Bustamante28Israel Fernandez Cadenas29Geoffrey Cloud30Geoffrey Cloud31Jane M. Maguire32Lisa Lincz33Lisa Lincz34Lisa Lincz35Timothy Kleinig36Timothy Kleinig37John Attia38John Attia39Simon Koblar40Simon Koblar41Monica Anne Hamilton-Bruce42Monica Anne Hamilton-Bruce43Philip Choi44Philip Choi45Bradford B. Worrall46Bradford B. Worrall47Robert L. Medcalf48Department of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, AustraliaAustralian Centre for Blood Diseases, Monash University, Melbourne, VIC, AustraliaAustralian Centre for Blood Diseases, Monash University, Melbourne, VIC, AustraliaDepartment of Cardiology, University Hospital of Bern, Bern, SwitzerlandBern Centre for Precision Medicine, Bern, SwitzerlandAustralian Centre for Blood Diseases, Monash University, Melbourne, VIC, AustraliaAustralian Centre for Blood Diseases, Monash University, Melbourne, VIC, AustraliaAustralian Centre for Blood Diseases, Monash University, Melbourne, VIC, AustraliaAustralian Centre for Blood Diseases, Monash University, Melbourne, VIC, AustraliaDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, AustraliaDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, AustraliaSydney Partnership for Health, Education, Research and Enterprise, Sydney, NSW, AustraliaDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, AustraliaDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, AustraliaDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, AustraliaDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, AustraliaNeurology Department, Royal Melbourne Hospital, Melbourne, VIC, AustraliaSchool of Medicine, University of New South Wales, Sydney, NSW, AustraliaNeurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain0Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Científicas (Spanish National Research Agency), University of Seville, Seville, Spain1Department of Neurology, Hospital Universitario Virgen Macarena, Seville, SpainNeurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain2Stroke Pharmacogenomics and Genetics Lab, Sant Pau Hospital Institute of Research, Barcelona, Spain3Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia4Department of Clinical Neuroscience, School of Nursing and Midwifery, Central Clinical School, Monash University, Melbourne, VIC, Australia5Department of Haematology, University of Technology Sydney, Sydney, NSW, AustraliaDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia6Haematology Department, Calvary Mater Newcastle, Waratah, NSW, Australia7Neurology Department, Royal Adelaide Hospital, Adelaide, SA, Australia8Adelaide Medical School, The University of Adelaide, Adelaide, SA, AustraliaDepartment of Neurology, John Hunter Hospital, Newcastle, NSW, AustraliaHunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia8Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia9Neurology, Central Adelaide Local Health Network, Adelaide, SA, Australia8Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia9Neurology, Central Adelaide Local Health Network, Adelaide, SA, Australia0Department of Neurosciences, Eastern Health, Melbourne, VIC, Australia1Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia2Department of Neurology, University of Virginia, Charlottesville, VA, United States3Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United StatesAustralian Centre for Blood Diseases, Monash University, Melbourne, VIC, AustraliaRationale: More than half of patients who receive thrombolysis for acute ischaemic stroke fail to recanalize. Elucidating biological factors which predict recanalization could identify therapeutic targets for increasing thrombolysis success.Hypothesis: We hypothesize that individual patient plasmin potential, as measured by in vitro response to recombinant tissue-type plasminogen activator (rt-PA), is a biomarker of rt-PA response, and that patients with greater plasmin response are more likely to recanalize early.Methods: This study will use historical samples from the Barcelona Stroke Thrombolysis Biobank, comprised of 350 pre-thrombolysis plasma samples from ischaemic stroke patients who received serial transcranial-Doppler (TCD) measurements before and after thrombolysis. The plasmin potential of each patient will be measured using the level of plasmin-antiplasmin complex (PAP) generated after in-vitro addition of rt-PA. Levels of antiplasmin, plasminogen, t-PA activity, and PAI-1 activity will also be determined. Association between plasmin potential variables and time to recanalization [assessed on serial TCD using the thrombolysis in brain ischemia (TIBI) score] will be assessed using Cox proportional hazards models, adjusted for potential confounders.Outcomes: The primary outcome will be time to recanalization detected by TCD (defined as TIBI ≥4). Secondary outcomes will be recanalization within 6-h and recanalization and/or haemorrhagic transformation at 24-h. This analysis will utilize an expanded cohort including ~120 patients from the Targeting Optimal Thrombolysis Outcomes (TOTO) study.Discussion: If association between proteolytic response to rt-PA and recanalization is confirmed, future clinical treatment may customize thrombolytic therapy to maximize outcomes and minimize adverse effects for individual patients.https://www.frontiersin.org/articles/10.3389/fneur.2020.589628/fullacute stroke therapyfibrinolysisrtPAthrombolysisplasminstroke
spellingShingle Thomas Lillicrap
Thomas Lillicrap
Charithani B. Keragala
Dominik F. Draxler
Dominik F. Draxler
Dominik F. Draxler
Jilly Chan
Heidi Ho
Stevi Harman
Be'eri Niego
Elizabeth Holliday
Elizabeth Holliday
Christopher R. Levi
Christopher R. Levi
Christopher R. Levi
Carlos Garcia-Esperon
Carlos Garcia-Esperon
Neil Spratt
Neil Spratt
Prajwal Gyawali
Prajwal Gyawali
Andrew Bivard
Andrew Bivard
Andrew Bivard
Mark W. Parsons
Joan Montaner
Joan Montaner
Joan Montaner
Alejandro Bustamante
Israel Fernandez Cadenas
Geoffrey Cloud
Geoffrey Cloud
Jane M. Maguire
Lisa Lincz
Lisa Lincz
Lisa Lincz
Timothy Kleinig
Timothy Kleinig
John Attia
John Attia
Simon Koblar
Simon Koblar
Monica Anne Hamilton-Bruce
Monica Anne Hamilton-Bruce
Philip Choi
Philip Choi
Bradford B. Worrall
Bradford B. Worrall
Robert L. Medcalf
Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank Samples
Frontiers in Neurology
acute stroke therapy
fibrinolysis
rtPA
thrombolysis
plasmin
stroke
title Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank Samples
title_full Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank Samples
title_fullStr Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank Samples
title_full_unstemmed Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank Samples
title_short Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank Samples
title_sort plasmin generation potential and recanalization in acute ischaemic stroke an observational cohort study of stroke biobank samples
topic acute stroke therapy
fibrinolysis
rtPA
thrombolysis
plasmin
stroke
url https://www.frontiersin.org/articles/10.3389/fneur.2020.589628/full
work_keys_str_mv AT thomaslillicrap plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT thomaslillicrap plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT charithanibkeragala plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT dominikfdraxler plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT dominikfdraxler plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT dominikfdraxler plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT jillychan plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT heidiho plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT steviharman plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT beeriniego plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT elizabethholliday plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT elizabethholliday plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT christopherrlevi plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT christopherrlevi plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT christopherrlevi plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT carlosgarciaesperon plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT carlosgarciaesperon plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT neilspratt plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT neilspratt plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT prajwalgyawali plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT prajwalgyawali plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT andrewbivard plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT andrewbivard plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT andrewbivard plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT markwparsons plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT joanmontaner plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT joanmontaner plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT joanmontaner plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT alejandrobustamante plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT israelfernandezcadenas plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT geoffreycloud plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT geoffreycloud plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT janemmaguire plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT lisalincz plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT lisalincz plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT lisalincz plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT timothykleinig plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT timothykleinig plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT johnattia plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT johnattia plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT simonkoblar plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT simonkoblar plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT monicaannehamiltonbruce plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT monicaannehamiltonbruce plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT philipchoi plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT philipchoi plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT bradfordbworrall plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT bradfordbworrall plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples
AT robertlmedcalf plasmingenerationpotentialandrecanalizationinacuteischaemicstrokeanobservationalcohortstudyofstrokebiobanksamples